[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUfMHkDlExk79baY1wdlcGf118FYRClYfSFRl68Fe7Kk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":30,"phaseBuckets":41,"rows":48},"Hasanuddin University",[4],56,false,11,3,13626,34,[13,15,17,19,22,24,26,28],{"name":14,"count":9},"Obesity",{"name":16,"count":9},"Nutritional Intervention",{"name":18,"count":9},"Schizophrenia Patients",{"name":20,"count":21},"Schizophrenia",2,{"name":23,"count":21},"Blood Glucose",{"name":25,"count":21},"Diabetes Mellitus (DM)",{"name":27,"count":21},"Functional Food",{"name":29,"count":21},"Stunting",[31,36],{"nctId":32,"briefTitle":33,"date":34,"intervention":35},"NCT06787222","Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome","2025-08-25","tretinoin 0.025% + Z. officinale patch",{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT07186478","I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis","2025-10-20","Investigational Drug",[42,43,44,45,46,47],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[49,75,93,115,144,172,190,208,235,253,280,307,336,354,372,390,416,443,470,488,513,535,562,580,606,631,657,675,698,724,742,769,800,818,836],{"intervention":35,"totalTrials":50,"cells":51},1,{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":71,"NA":73},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":54},[],{"trials":60,"activeCount":50,"soonestReadout":34},[61],{"nctId":32,"briefTitle":33,"status":62,"phases":63,"primaryCompletion":34,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":69},"ACTIVE_NOT_RECRUITING",[44,45],"2025-10-31","2024-11-03",26,[68],"Acne Vulgaris",[35,70],"tretinoin 0.025% cream",{"trials":72,"activeCount":54},[],{"trials":74,"activeCount":54},[],{"intervention":70,"totalTrials":50,"cells":76},{"EARLY_PHASE1":77,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":89,"NA":91},{"trials":78,"activeCount":54},[],{"trials":80,"activeCount":54},[],{"trials":82,"activeCount":54},[],{"trials":84,"activeCount":50,"soonestReadout":34},[85],{"nctId":32,"briefTitle":33,"status":62,"phases":86,"primaryCompletion":34,"completion":64,"start":65,"enrollment":66,"conditions":87,"interventions":88},[44,45],[68],[35,70],{"trials":90,"activeCount":54},[],{"trials":92,"activeCount":54},[],{"intervention":40,"totalTrials":50,"cells":94},{"EARLY_PHASE1":95,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":105},{"trials":96,"activeCount":54},[],{"trials":98,"activeCount":54},[],{"trials":100,"activeCount":54},[],{"trials":102,"activeCount":54},[],{"trials":104,"activeCount":54},[],{"trials":106,"activeCount":50,"soonestReadout":39},[107],{"nctId":37,"briefTitle":38,"status":62,"phases":108,"primaryCompletion":39,"completion":39,"start":109,"enrollment":110,"conditions":111,"interventions":114},[47],"2024-12-17",112,[112,113],"Pulmonary Tuberculosis","Hypoalbuminemia",[40],{"intervention":116,"totalTrials":50,"cells":117},"Mirabegron 50 MG",{"EARLY_PHASE1":118,"PHASE1":120,"PHASE2":122,"PHASE3":124,"PHASE4":126,"NA":142},{"trials":119,"activeCount":54},[],{"trials":121,"activeCount":54},[],{"trials":123,"activeCount":54},[],{"trials":125,"activeCount":54},[],{"trials":127,"activeCount":54},[128],{"nctId":129,"briefTitle":130,"status":131,"phases":132,"primaryCompletion":133,"completion":134,"start":135,"enrollment":136,"conditions":137,"interventions":141},"NCT06124066","THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS","COMPLETED",[46],"2022-09-30","2022-10-30","2022-07-01",42,[138,139,140],"Ureteral Stone","Kidney Stones","Ureteral Stenosis",[116],{"trials":143,"activeCount":54},[],{"intervention":145,"totalTrials":50,"cells":146},"honey",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":170},{"trials":148,"activeCount":54},[],{"trials":150,"activeCount":54},[],{"trials":152,"activeCount":54},[],{"trials":154,"activeCount":54},[],{"trials":156,"activeCount":54},[157],{"nctId":158,"briefTitle":159,"status":131,"phases":160,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":167},"NCT05946005","Lidocaine, Povidone Iodine, and Honey Application on Second-degree Perineal Tear Healing",[46],"2022-04-15","2022-05-31","2021-12-01",200,[166],"Perineal Tear",[145,168,169],"lidocaine","povidone-iodine",{"trials":171,"activeCount":54},[],{"intervention":168,"totalTrials":50,"cells":173},{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":188},{"trials":175,"activeCount":54},[],{"trials":177,"activeCount":54},[],{"trials":179,"activeCount":54},[],{"trials":181,"activeCount":54},[],{"trials":183,"activeCount":54},[184],{"nctId":158,"briefTitle":159,"status":131,"phases":185,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":186,"interventions":187},[46],[166],[145,168,169],{"trials":189,"activeCount":54},[],{"intervention":169,"totalTrials":50,"cells":191},{"EARLY_PHASE1":192,"PHASE1":194,"PHASE2":196,"PHASE3":198,"PHASE4":200,"NA":206},{"trials":193,"activeCount":54},[],{"trials":195,"activeCount":54},[],{"trials":197,"activeCount":54},[],{"trials":199,"activeCount":54},[],{"trials":201,"activeCount":54},[202],{"nctId":158,"briefTitle":159,"status":131,"phases":203,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":204,"interventions":205},[46],[166],[145,168,169],{"trials":207,"activeCount":54},[],{"intervention":209,"totalTrials":50,"cells":210},"Prolotherapy",{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":233},{"trials":212,"activeCount":54},[],{"trials":214,"activeCount":54},[],{"trials":216,"activeCount":54},[],{"trials":218,"activeCount":54},[],{"trials":220,"activeCount":54},[221],{"nctId":222,"briefTitle":223,"status":131,"phases":224,"primaryCompletion":225,"completion":226,"start":227,"enrollment":228,"conditions":229,"interventions":231},"NCT04557943","Prolotherapy Intervention Effect in Patient With Knee Osteoarthritis",[46],"2020-04-30","2020-08-01","2019-09-01",36,[230],"Knee Osteoarthritis",[209,232],"Sodium Hyaluronate",{"trials":234,"activeCount":54},[],{"intervention":232,"totalTrials":50,"cells":236},{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":243,"PHASE4":245,"NA":251},{"trials":238,"activeCount":54},[],{"trials":240,"activeCount":54},[],{"trials":242,"activeCount":54},[],{"trials":244,"activeCount":54},[],{"trials":246,"activeCount":54},[247],{"nctId":222,"briefTitle":223,"status":131,"phases":248,"primaryCompletion":225,"completion":226,"start":227,"enrollment":228,"conditions":249,"interventions":250},[46],[230],[209,232],{"trials":252,"activeCount":54},[],{"intervention":254,"totalTrials":50,"cells":255},"Fixed Drug Combination",{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":276,"NA":278},{"trials":257,"activeCount":54},[],{"trials":259,"activeCount":54},[],{"trials":261,"activeCount":54},[],{"trials":263,"activeCount":54},[264],{"nctId":265,"briefTitle":266,"status":267,"phases":268,"primaryCompletion":269,"completion":270,"start":135,"enrollment":271,"conditions":272,"interventions":275},"NCT05376189","Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis","UNKNOWN",[44,45],"2022-12-30","2023-02-01",37,[273,274],"Spondylitis","Tuberculosis",[254],{"trials":277,"activeCount":54},[],{"trials":279,"activeCount":54},[],{"intervention":281,"totalTrials":50,"cells":282},"Vitamin D",{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":303,"NA":305},{"trials":284,"activeCount":54},[],{"trials":286,"activeCount":54},[],{"trials":288,"activeCount":54},[],{"trials":290,"activeCount":54},[291],{"nctId":292,"briefTitle":293,"status":131,"phases":294,"primaryCompletion":295,"completion":296,"start":297,"enrollment":298,"conditions":299,"interventions":302},"NCT06706271","The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease",[44,45],"2024-08-01","2024-09-02","2023-05-01",43,[300,301],"Chronic Kidney Disease Stage 1","Chronic Kidney Disease Stage 2",[281],{"trials":304,"activeCount":54},[],{"trials":306,"activeCount":54},[],{"intervention":308,"totalTrials":50,"cells":309},"GABA",{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":330,"PHASE4":332,"NA":334},{"trials":311,"activeCount":54},[],{"trials":313,"activeCount":54},[],{"trials":315,"activeCount":54},[316],{"nctId":317,"briefTitle":318,"status":131,"phases":319,"primaryCompletion":320,"completion":321,"start":322,"enrollment":323,"conditions":324,"interventions":326},"NCT07477288","Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging",[44],"2025-09-26","2025-12-29","2025-03-12",44,[325],"Skin Aging",[308,327,328,329],"DMAE","Cysteamine","Bakuchiol",{"trials":331,"activeCount":54},[],{"trials":333,"activeCount":54},[],{"trials":335,"activeCount":54},[],{"intervention":327,"totalTrials":50,"cells":337},{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":348,"PHASE4":350,"NA":352},{"trials":339,"activeCount":54},[],{"trials":341,"activeCount":54},[],{"trials":343,"activeCount":54},[344],{"nctId":317,"briefTitle":318,"status":131,"phases":345,"primaryCompletion":320,"completion":321,"start":322,"enrollment":323,"conditions":346,"interventions":347},[44],[325],[308,327,328,329],{"trials":349,"activeCount":54},[],{"trials":351,"activeCount":54},[],{"trials":353,"activeCount":54},[],{"intervention":328,"totalTrials":50,"cells":355},{"EARLY_PHASE1":356,"PHASE1":358,"PHASE2":360,"PHASE3":366,"PHASE4":368,"NA":370},{"trials":357,"activeCount":54},[],{"trials":359,"activeCount":54},[],{"trials":361,"activeCount":54},[362],{"nctId":317,"briefTitle":318,"status":131,"phases":363,"primaryCompletion":320,"completion":321,"start":322,"enrollment":323,"conditions":364,"interventions":365},[44],[325],[308,327,328,329],{"trials":367,"activeCount":54},[],{"trials":369,"activeCount":54},[],{"trials":371,"activeCount":54},[],{"intervention":329,"totalTrials":50,"cells":373},{"EARLY_PHASE1":374,"PHASE1":376,"PHASE2":378,"PHASE3":384,"PHASE4":386,"NA":388},{"trials":375,"activeCount":54},[],{"trials":377,"activeCount":54},[],{"trials":379,"activeCount":54},[380],{"nctId":317,"briefTitle":318,"status":131,"phases":381,"primaryCompletion":320,"completion":321,"start":322,"enrollment":323,"conditions":382,"interventions":383},[44],[325],[308,327,328,329],{"trials":385,"activeCount":54},[],{"trials":387,"activeCount":54},[],{"trials":389,"activeCount":54},[],{"intervention":391,"totalTrials":50,"cells":392},"Risperidone 2 mg",{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":410,"PHASE4":412,"NA":414},{"trials":394,"activeCount":54},[],{"trials":396,"activeCount":54},[],{"trials":398,"activeCount":54},[399],{"nctId":400,"briefTitle":401,"status":131,"phases":402,"primaryCompletion":403,"completion":403,"start":404,"enrollment":405,"conditions":406,"interventions":409},"NCT07477301","Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia",[44],"2025-02-28","2024-12-01",46,[20,407,408],"Cognitive Dysfunction","Inflamation",[391],{"trials":411,"activeCount":54},[],{"trials":413,"activeCount":54},[],{"trials":415,"activeCount":54},[],{"intervention":417,"totalTrials":50,"cells":418},"Ashwagandha",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":437,"PHASE4":439,"NA":441},{"trials":420,"activeCount":54},[],{"trials":422,"activeCount":54},[],{"trials":424,"activeCount":54},[425],{"nctId":426,"briefTitle":427,"status":131,"phases":428,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":433,"interventions":435},"NCT07575516","Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone",[44],"2026-01-30","2026-01-31","2025-10-01",80,[18,434],"Neuroinflammation",[436,417],"Risperidone 4mg\u002Fday",{"trials":438,"activeCount":54},[],{"trials":440,"activeCount":54},[],{"trials":442,"activeCount":54},[],{"intervention":444,"totalTrials":50,"cells":445},"Eucalyptus Oil",{"EARLY_PHASE1":446,"PHASE1":448,"PHASE2":450,"PHASE3":464,"PHASE4":466,"NA":468},{"trials":447,"activeCount":54},[],{"trials":449,"activeCount":54},[],{"trials":451,"activeCount":54},[452],{"nctId":453,"briefTitle":454,"status":131,"phases":455,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":460,"interventions":462},"NCT05398965","Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)",[44],"2021-01-28","2022-03-01","2020-11-18",54,[461],"COVID-19",[444,463],"Standard COVID medication",{"trials":465,"activeCount":54},[],{"trials":467,"activeCount":54},[],{"trials":469,"activeCount":54},[],{"intervention":463,"totalTrials":50,"cells":471},{"EARLY_PHASE1":472,"PHASE1":474,"PHASE2":476,"PHASE3":482,"PHASE4":484,"NA":486},{"trials":473,"activeCount":54},[],{"trials":475,"activeCount":54},[],{"trials":477,"activeCount":54},[478],{"nctId":453,"briefTitle":454,"status":131,"phases":479,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":480,"interventions":481},[44],[461],[444,463],{"trials":483,"activeCount":54},[],{"trials":485,"activeCount":54},[],{"trials":487,"activeCount":54},[],{"intervention":436,"totalTrials":21,"cells":489},{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":500,"PHASE4":502,"NA":504},{"trials":491,"activeCount":54},[],{"trials":493,"activeCount":54},[],{"trials":495,"activeCount":54},[496],{"nctId":426,"briefTitle":427,"status":131,"phases":497,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":498,"interventions":499},[44],[18,434],[436,417],{"trials":501,"activeCount":54},[],{"trials":503,"activeCount":54},[],{"trials":505,"activeCount":54},[506],{"nctId":507,"briefTitle":508,"status":131,"phases":509,"primaryCompletion":430,"completion":430,"start":510,"enrollment":432,"conditions":511,"interventions":512},"NCT07541157","Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients",[47],"2025-09-01",[18],[436],{"intervention":514,"totalTrials":50,"cells":515},"Risperidone 4 to 6 mg\u002Fday",{"EARLY_PHASE1":516,"PHASE1":518,"PHASE2":520,"PHASE3":522,"PHASE4":524,"NA":526},{"trials":517,"activeCount":54},[],{"trials":519,"activeCount":54},[],{"trials":521,"activeCount":54},[],{"trials":523,"activeCount":54},[],{"trials":525,"activeCount":54},[],{"trials":527,"activeCount":54},[528],{"nctId":529,"briefTitle":530,"status":131,"phases":531,"primaryCompletion":430,"completion":430,"start":532,"enrollment":136,"conditions":533,"interventions":534},"NCT07609953","Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia",[47],"2025-11-01",[20],[514],{"intervention":536,"totalTrials":50,"cells":537},"Topical Ethanol Extract",{"EARLY_PHASE1":538,"PHASE1":540,"PHASE2":542,"PHASE3":544,"PHASE4":546,"NA":548},{"trials":539,"activeCount":54},[],{"trials":541,"activeCount":54},[],{"trials":543,"activeCount":54},[],{"trials":545,"activeCount":54},[],{"trials":547,"activeCount":54},[],{"trials":549,"activeCount":54},[550],{"nctId":551,"briefTitle":552,"status":267,"phases":553,"primaryCompletion":554,"completion":555,"start":556,"enrollment":557,"conditions":558,"interventions":560},"NCT05622916","Topical Ethanol Extract (Piper Crocatum) for Anogenital Warts",[47],"2023-02-28","2023-04-30","2022-11-30",100,[559],"Anogenital Wart",[536,561],"Trichloroacetic Acid Topical",{"intervention":561,"totalTrials":50,"cells":563},{"EARLY_PHASE1":564,"PHASE1":566,"PHASE2":568,"PHASE3":570,"PHASE4":572,"NA":574},{"trials":565,"activeCount":54},[],{"trials":567,"activeCount":54},[],{"trials":569,"activeCount":54},[],{"trials":571,"activeCount":54},[],{"trials":573,"activeCount":54},[],{"trials":575,"activeCount":54},[576],{"nctId":551,"briefTitle":552,"status":267,"phases":577,"primaryCompletion":554,"completion":555,"start":556,"enrollment":557,"conditions":578,"interventions":579},[47],[559],[536,561],{"intervention":581,"totalTrials":50,"cells":582},"Post-operative Analgesia",{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":591,"NA":593},{"trials":584,"activeCount":54},[],{"trials":586,"activeCount":54},[],{"trials":588,"activeCount":54},[],{"trials":590,"activeCount":54},[],{"trials":592,"activeCount":54},[],{"trials":594,"activeCount":54},[595],{"nctId":596,"briefTitle":597,"status":131,"phases":598,"primaryCompletion":599,"completion":599,"start":600,"enrollment":601,"conditions":602,"interventions":605},"NCT07303309","Effectiveness of High-Voltage PRF for Chronic Lumbosacral Radicular Pain",[47],"2025-04-29","2025-02-07",22,[603,604],"Lumbosacral Radicular Pain","Chronic Radicular Back Pain",[581],{"intervention":607,"totalTrials":50,"cells":608},"Fluoxetine",{"EARLY_PHASE1":609,"PHASE1":611,"PHASE2":613,"PHASE3":615,"PHASE4":617,"NA":619},{"trials":610,"activeCount":54},[],{"trials":612,"activeCount":54},[],{"trials":614,"activeCount":54},[],{"trials":616,"activeCount":54},[],{"trials":618,"activeCount":54},[],{"trials":620,"activeCount":54},[621],{"nctId":622,"briefTitle":623,"status":131,"phases":624,"primaryCompletion":625,"completion":625,"start":626,"enrollment":627,"conditions":628,"interventions":630},"NCT07521358","Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression",[47],"2025-08-01","2025-07-01",40,[629],"Major Depressive Disorder (MDD)",[607],{"intervention":632,"totalTrials":50,"cells":633},"PECS II block",{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":640,"PHASE4":642,"NA":644},{"trials":635,"activeCount":54},[],{"trials":637,"activeCount":54},[],{"trials":639,"activeCount":54},[],{"trials":641,"activeCount":54},[],{"trials":643,"activeCount":54},[],{"trials":645,"activeCount":54},[646],{"nctId":647,"briefTitle":648,"status":131,"phases":649,"primaryCompletion":650,"completion":650,"start":651,"enrollment":652,"conditions":653,"interventions":655},"NCT06451705","Pecs Block vs Local Infiltration in Mastectomy",[47],"2024-04-30","2024-03-01",30,[654],"Pain, Postoperative",[632,656],"LIA",{"intervention":656,"totalTrials":50,"cells":658},{"EARLY_PHASE1":659,"PHASE1":661,"PHASE2":663,"PHASE3":665,"PHASE4":667,"NA":669},{"trials":660,"activeCount":54},[],{"trials":662,"activeCount":54},[],{"trials":664,"activeCount":54},[],{"trials":666,"activeCount":54},[],{"trials":668,"activeCount":54},[],{"trials":670,"activeCount":54},[671],{"nctId":647,"briefTitle":648,"status":131,"phases":672,"primaryCompletion":650,"completion":650,"start":651,"enrollment":652,"conditions":673,"interventions":674},[47],[654],[632,656],{"intervention":676,"totalTrials":50,"cells":677},"risperidone",{"EARLY_PHASE1":678,"PHASE1":680,"PHASE2":682,"PHASE3":684,"PHASE4":686,"NA":688},{"trials":679,"activeCount":54},[],{"trials":681,"activeCount":54},[],{"trials":683,"activeCount":54},[],{"trials":685,"activeCount":54},[],{"trials":687,"activeCount":54},[],{"trials":689,"activeCount":54},[690],{"nctId":691,"briefTitle":692,"status":131,"phases":693,"primaryCompletion":430,"completion":430,"start":532,"enrollment":694,"conditions":695,"interventions":697},"NCT07524868","Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients",[47],50,[18,696],"Auditory Hallucination",[676],{"intervention":699,"totalTrials":50,"cells":700},"10% Dextrose",{"EARLY_PHASE1":701,"PHASE1":703,"PHASE2":705,"PHASE3":707,"PHASE4":709,"NA":711},{"trials":702,"activeCount":54},[],{"trials":704,"activeCount":54},[],{"trials":706,"activeCount":54},[],{"trials":708,"activeCount":54},[],{"trials":710,"activeCount":54},[],{"trials":712,"activeCount":54},[713],{"nctId":714,"briefTitle":715,"status":131,"phases":716,"primaryCompletion":717,"completion":718,"start":719,"enrollment":652,"conditions":720,"interventions":722},"NCT04206579","Oral Dextrose Formula in Performance of Soccer Athlete",[47],"2019-05-28","2019-06-30","2019-03-25",[721],"Athletes",[699,723],"Natrium Dextrose",{"intervention":723,"totalTrials":50,"cells":725},{"EARLY_PHASE1":726,"PHASE1":728,"PHASE2":730,"PHASE3":732,"PHASE4":734,"NA":736},{"trials":727,"activeCount":54},[],{"trials":729,"activeCount":54},[],{"trials":731,"activeCount":54},[],{"trials":733,"activeCount":54},[],{"trials":735,"activeCount":54},[],{"trials":737,"activeCount":54},[738],{"nctId":714,"briefTitle":715,"status":131,"phases":739,"primaryCompletion":717,"completion":718,"start":719,"enrollment":652,"conditions":740,"interventions":741},[47],[721],[699,723],{"intervention":743,"totalTrials":50,"cells":744},"5% Dextrose",{"EARLY_PHASE1":745,"PHASE1":747,"PHASE2":749,"PHASE3":751,"PHASE4":753,"NA":755},{"trials":746,"activeCount":54},[],{"trials":748,"activeCount":54},[],{"trials":750,"activeCount":54},[],{"trials":752,"activeCount":54},[],{"trials":754,"activeCount":54},[],{"trials":756,"activeCount":54},[757],{"nctId":758,"briefTitle":759,"status":131,"phases":760,"primaryCompletion":761,"completion":762,"start":763,"enrollment":764,"conditions":765,"interventions":768},"NCT04150978","High Protein Formula on Enteral Feeding in Clinical Improvement and Malnutrition at Intensive Care Unit Patients",[47],"2018-03-31","2018-07-07","2017-10-01",60,[766,767],"Critically Ill","Intensive Care Unit",[743],{"intervention":770,"totalTrials":50,"cells":771},"Trigona sp honey with the buccal fat pad technique",{"EARLY_PHASE1":772,"PHASE1":774,"PHASE2":776,"PHASE3":778,"PHASE4":780,"NA":782},{"trials":773,"activeCount":54},[],{"trials":775,"activeCount":54},[],{"trials":777,"activeCount":54},[],{"trials":779,"activeCount":54},[],{"trials":781,"activeCount":54},[],{"trials":783,"activeCount":54},[784],{"nctId":785,"briefTitle":786,"status":131,"phases":787,"primaryCompletion":788,"completion":789,"start":790,"enrollment":791,"conditions":792,"interventions":797},"NCT07610993","Evaluating Salivary α - Amylase Levels Following Trigona Sp Honey Application To Post Palatoplasty Patients: A Pilot Randomized Clinical Study",[47],"2025-06-01","2025-08-06","2024-06-01",24,[793,794,795,796],"Buccal Fat Pad","Cleft Palate","Honey","Salivary Alpha Amylase",[770,798,799],"framicetyn sulfate dressing with the buccal fat pad technique","framicetyn sulfate dressing without the buccal fat pad technique",{"intervention":798,"totalTrials":50,"cells":801},{"EARLY_PHASE1":802,"PHASE1":804,"PHASE2":806,"PHASE3":808,"PHASE4":810,"NA":812},{"trials":803,"activeCount":54},[],{"trials":805,"activeCount":54},[],{"trials":807,"activeCount":54},[],{"trials":809,"activeCount":54},[],{"trials":811,"activeCount":54},[],{"trials":813,"activeCount":54},[814],{"nctId":785,"briefTitle":786,"status":131,"phases":815,"primaryCompletion":788,"completion":789,"start":790,"enrollment":791,"conditions":816,"interventions":817},[47],[793,794,795,796],[770,798,799],{"intervention":799,"totalTrials":50,"cells":819},{"EARLY_PHASE1":820,"PHASE1":822,"PHASE2":824,"PHASE3":826,"PHASE4":828,"NA":830},{"trials":821,"activeCount":54},[],{"trials":823,"activeCount":54},[],{"trials":825,"activeCount":54},[],{"trials":827,"activeCount":54},[],{"trials":829,"activeCount":54},[],{"trials":831,"activeCount":54},[832],{"nctId":785,"briefTitle":786,"status":131,"phases":833,"primaryCompletion":788,"completion":789,"start":790,"enrollment":791,"conditions":834,"interventions":835},[47],[793,794,795,796],[770,798,799],{"intervention":837,"totalTrials":50,"cells":838},"PRF group",{"EARLY_PHASE1":839,"PHASE1":841,"PHASE2":843,"PHASE3":845,"PHASE4":847,"NA":849},{"trials":840,"activeCount":54},[],{"trials":842,"activeCount":54},[],{"trials":844,"activeCount":54},[],{"trials":846,"activeCount":54},[],{"trials":848,"activeCount":54},[],{"trials":850,"activeCount":54},[851],{"nctId":852,"briefTitle":853,"status":131,"phases":854,"primaryCompletion":855,"completion":856,"start":857,"enrollment":858,"conditions":859,"interventions":863},"NCT07600619","Salivary α-Amylase as a Non-Invasive Biomarker of PRF-Enhanced Wound Healing After Third Molar Surgery",[47],"2024-11-24","2024-12-22","2024-05-12",28,[860,861,862,796],"Platelet-Rich Fibrin (PRF)","Impacted Mandibular Third Molar","Postoperative Wound Healing",[837]]